Lexeo Therapeutics, Inc. (LXEO) › Weighted Average Diluted SharesLexeo Therapeutics, Inc. (LXEO) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-12-31: 1.63M2023-12-31: 5.35M2024-12-31: 31.79M2025-12-31: 53.65M53.65M2022-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3153.65M+68.8%2026-03-30From 2025-01-012024-12-3131.79M+493.7%2026-03-30From 2024-01-012023-12-315.35M+228.4%2025-03-24From 2023-01-012022-12-311.63M—2024-03-11From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)